Navion

Navion is a privately held pre-clinical stage biotechnology company based on the licensed intellectual property portfolio of University of Virginia researcher Manoj Patel. Navion aims to create therapies targeting mutations of sodium and other ion channels that cause rare genetic epilepsies and other treatment-resistant epilepsies.